Variant report

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr7:106704997..106706792-chr7:106715198..106717254,2	MCF-7	breast:
2	chr7:106716669..106718547-chr7:106773467..106775452,2	K562	blood:

Variant related genes	Relation type
ENSG00000243193	Chromatin interaction

rSNPs within LD-proxies of this variant (count:27)

rs_ID	r²[population]
rs10281856	0.83[JPT][hapmap]
rs10953528	0.82[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs12667954	1.00[JPT][hapmap];0.85[ASN][1000 genomes]
rs12669339	0.94[AMR][1000 genomes];0.97[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs12674011	0.91[ASN][1000 genomes]
rs12705402	1.00[JPT][hapmap];0.91[ASN][1000 genomes]
rs12705403	1.00[JPT][hapmap];0.85[ASN][1000 genomes]
rs1860803	0.83[JPT][hapmap]
rs2237652	0.81[CHB][hapmap];1.00[JPT][hapmap];0.83[ASN][1000 genomes]
rs2237654	0.84[CHB][hapmap];1.00[JPT][hapmap];0.83[ASN][1000 genomes]
rs2237656	1.00[JPT][hapmap];0.81[ASN][1000 genomes]
rs2237657	0.81[ASN][1000 genomes]
rs2283037	0.89[ASN][1000 genomes]
rs2302453	1.00[JPT][hapmap]
rs3735613	0.80[CHB][hapmap];1.00[JPT][hapmap];0.89[ASN][1000 genomes]
rs3801969	1.00[CHB][hapmap];1.00[JPT][hapmap];0.94[AMR][1000 genomes];0.96[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs62483580	0.91[ASN][1000 genomes]
rs62483581	0.91[ASN][1000 genomes]
rs6466157	0.91[ASN][1000 genomes]
rs6466158	0.90[ASN][1000 genomes]
rs6952920	0.91[ASN][1000 genomes]
rs6969719	0.82[JPT][hapmap]
rs717099	0.83[JPT][hapmap]
rs7790497	0.91[ASN][1000 genomes]
rs7809330	1.00[JPT][hapmap];0.81[ASN][1000 genomes]
rs917760	0.81[CHB][hapmap];1.00[JPT][hapmap];0.85[ASN][1000 genomes]
rs9648946	0.81[CHB][hapmap];1.00[JPT][hapmap]

Variant overlapped rSNPs/rCNVs (count:1 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv831087	chr7:106673465-106872460	Active TSS Enhancers Flanking Active TSS Strong transcription ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	29 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:13 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:106706400-106718600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr7:106706400-106720000	Weak transcription	Spleen	Spleen
3	chr7:106706800-106719200	Weak transcription	Fetal Brain Male	brain
4	chr7:106708800-106718600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
5	chr7:106710200-106720000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
6	chr7:106712200-106719000	Weak transcription	Brain Anterior Caudate	brain
7	chr7:106716000-106716800	Enhancers	HUVEC	blood vessel
8	chr7:106716000-106717800	Flanking Active TSS	K562	blood
9	chr7:106716000-106721400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr7:106716000-106721400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr7:106716200-106717400	Weak transcription	Primary hematopoietic stem cells	blood
12	chr7:106716600-106716800	Enhancers	Primary hematopoietic stem cells short term culture	blood
13	chr7:106716600-106717600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland

Quick Search: